Chemoinformaics analysis of 7-HYDROXY-6-(3-METHYLBUT-2-ENYL)CHROMEN-2-ONE
| Molecular Weight | 230.263 | nRot | 2 |
| Heavy Atom Molecular Weight | 216.151 | nRig | 17 |
| Exact Molecular Weight | 230.094 | nRing | 2 |
| Solubility: LogS | -3.668 | nHRing | 1 |
| Solubility: LogP | 2.676 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 35.1211 |
| nHD | 1 | BPOL | 16.6489 |
| QED | 0.735 |
| Synth | 2.406 |
| Natural Product Likeliness | 1.087 |
| NR-PPAR-gamma | 0.647 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.995 |
| Pgp-sub | 0 |
| HIA | 0.014 |
| CACO-2 | -4.685 |
| MDCK | 0.000032 |
| BBB | 0.036 |
| PPB | 0.761299 |
| VDSS | 1.019 |
| FU | 0.265542 |
| CYP1A2-inh | 0.611 |
| CYP1A2-sub | 0.983 |
| CYP2c19-inh | 0.393 |
| CYP2c19-sub | 0.867 |
| CYP2c9-inh | 0.584 |
| CYP2c9-sub | 0.899 |
| CYP2d6-inh | 0.056 |
| CYP2d6-sub | 0.869 |
| CYP3a4-inh | 0.375 |
| CYP3a4-sub | 0.587 |
| CL | 2.897 |
| T12 | 0.531 |
| hERG | 0.09 |
| Ames | 0.557 |
| ROA | 0.645 |
| SkinSen | 0.652 |
| Carcinogencity | 0.071 |
| EI | 0.325 |
| Respiratory | 0.12 |
| NR-Aromatase | 0.852 |
| Antiviral | No |
| Prediction | 0.732373 |